Merck Launches Praziquantel Donation Program

News: US drugmaker Merck & Co has launched the Praziquantel Donation Program 2013, in collaboration with the World Health Organization (WHO), to combat schistosomiasis in Sudan. Merck will donate 6mn Praziquantel tablets worth nearly SDG2.4mn (US$541.40) through the WHO. The WHO has listed Praziquantel as an essential drug and estimates that about 5.8mn people in Sudan (around 15% of the country's population) suffer from schistosomiasis. Under the donation campaign, around 1.6mn tablets will be distributed through 17 administrative units, while another 4.4mn tablets will be administered in schools in the Sudanese states of Khartoum, Gedarif, Kassala and North Kordofan.

Merck Launches Praziquantel Donation Program

News: US drugmaker Merck & Co has launched the Praziquantel Donation Program 2013, in collaboration with the World Health Organization (WHO), to combat schistosomiasis in Sudan. Merck will donate 6mn Praziquantel tablets worth nearly SDG2.4mn (US$541.40) through the WHO. The WHO has listed Praziquantel as an essential drug and estimates that about 5.8mn people in Sudan (around 15% of the country's population) suffer from schistosomiasis. Under the donation campaign, around 1.6mn tablets will be distributed through 17 administrative units, while another 4.4mn tablets will be administered in schools in the Sudanese states of Khartoum, Gedarif, Kassala and North Kordofan.

×

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

×

REQUEST A DEMO

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

A member of the team will be in touch shortly to arrange a convenient time for your free demonstration and trial. If your enquiry is urgent, please email our Client Services team here.